BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arteaga Cabeza O, Mikrogeorgiou A, Kannan S, Ferriero DM. Advanced nanotherapies to promote neuroregeneration in the injured newborn brain. Adv Drug Deliv Rev 2019;148:19-37. [PMID: 31678359 DOI: 10.1016/j.addr.2019.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Metallinou D, Lazarou E, Lykeridou A. Pharmacological and Non-Pharmacological Brain-Focused Clinical Practices for Premature Neonates at High Risk of Neuronal Injury. Maedica (Bucur) 2021;16:281-90. [PMID: 34621352 DOI: 10.26574/maedica.2020.16.2.281] [Reference Citation Analysis]
2 Narayanamurthy R, Yang JJ, Yager JY, Unsworth LD. Drug delivery platforms for neonatal brain injury. J Control Release 2021;330:765-87. [PMID: 33417984 DOI: 10.1016/j.jconrel.2020.12.056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Zhou W, Fu Y, Zhang M, Buabeid MA, Ijaz M, Murtaza G. Nanoparticle-mediated therapy of neuronal damage in the neonatal brain. Journal of Drug Delivery Science and Technology 2021;61:102208. [DOI: 10.1016/j.jddst.2020.102208] [Reference Citation Analysis]
4 Arteaga Cabeza O, Zhang Z, Smith Khoury E, Sheldon RA, Sharma A, Zhang F, Slusher BS, Kannan RM, Kannan S, Ferriero DM. Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury. Neurobiol Dis 2021;148:105201. [PMID: 33271328 DOI: 10.1016/j.nbd.2020.105201] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Basargina MA, Fisenko AP, Bombardirova EP, Smirnov IE, Kharitonova NA, Illarionova MS. MODELING OF THE SANOGENETIC DEVELOPING ENVIRONMENT AND STARTING NON-DRUG HABILITATION OF PREMATURE INFANTS. RPJ 2019;22:380-387. [DOI: 10.18821/1560-9561-2019-22-6-380-387] [Reference Citation Analysis]
6 Lowe TL, Agrahari V, Kannan RM, Kannan S. Nanotechnology enabled regenerative medicine for neurological disorders. Adv Drug Deliv Rev 2019;148:1-2. [PMID: 31787167 DOI: 10.1016/j.addr.2019.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]